What We Saw
Biogas producers use anaerobic digesters (AD) to divert waste from landfills and turn it into renewable energy, but the process is highly artisanal and inefficient. New tools could increase efficiency, enabling AD as a versatile platform for chemical and fuel manufacturing.
The Solution We Built
Alchemyca’s solution integrates advanced digital twins and biological catalysts for measurement and stimulation of biogas plants, making it easy for plant operators to improve system efficiency by up to 50 percent. This efficiency will eventually make organic waste a viable, low-cost feedstock for producing many versatile chemicals and fuels beyond renewable natural gas.
Press
Soon
The Problem We Saw
Emerging contaminants ranging from the ‘forever chemicals’ to carcinogenic chemical byproducts have polluted our water, air and soils. Simultaneously, chemical and mechanical remediation technologies had seemingly plateaued, leaving industry and governments with few tools to address these acute pollutants.
The Solution We Built
Allonnia harnesses biotechnology in synergy with mechanical and chemical tools to tackle complex industrial pollutants. Launched with research leader Battelle and O&G major Suncor, Allonnia has developed bio-solutions spanning the full ‘Detect - Collect - Destroy’ pipeline for waste remediation against targets such as PFAS and dioxanes.
The Problem We Saw
Beauty brands struggled to meet new rising consumer values without sacrificing product performance. There was limited innovation in the ingredients they used, and a stark tradeoff between performance and sustainable positioning.
The Solution We Built
Arcaea approaches beauty through a biology first lens, bringing biotech-based ingredients and unique stories to brands and consumers. We partnered with entrepreneur and CEO, Jasmina Aganovic, as well as iconic bands (Chanel), innovative category disruptors (Olaplex) and sophisticated suppliers (Givaudan) to build Arcaea.
The Problem We Saw
The rise of science backed nutrition for health and wellness, as an alternative to prescription medicines, is a global megatrend. For millennia, we’ve turned to plants and herbs for health and healing, but we’re only beginning to map the universe of these bioactive molecules and micronutrients.
The Solution We Built
Ayana Bio integrates computational plant pathway discovery, synthetic biology, and plant cell culture to uncover and produce plant bioactives using sustainable production technology. Ayana can find, create, and scale complex molecules and molecular blends that have otherwise been locked away in plants with often challenging supply chains., former EVP of Innovation at Elanco.
The Problem We Saw
Livestock producers are urgently calling for new products to address antibiotic resistance and improve livestock sustainability. At the same time, the biotechnology tool stack had emerged to measure, understand and perturb the animal microbiome to drive health and productivity with more targeted solutions.
The Solution We Built
In partnership with Elanco, we developed BiomEdit, a company creating probiotics and microbial medicines for animal health. BiomEdit focuses on the greatest innovation needs in animal health, including medicated feed ingredients and therapeutics for livestock and pets. BiomEdit is led by CEO, Aaron Schacht, former EVP of Innovation at Elanco.
The Problem We Saw
Even as consumers called for new solutions across health areas such as weight loss, longevity, and mental health, consumer nutrition brands were ‘stuck’ with legacy probiotic strains discovered decades ago, with no ability to translate powerful advances in microbiome science into meaningful new ingredient palettes.
The Solution We Built
Verb Biotics is a ‘biotic’ ingredient developer leapfrogging incumbents with effective and purpose-designed probiotics. Verb drives toward deep understanding around the mechanism of action of its probiotics, designing a new wave of biotics with truly meaningful ‘feel the effect’ benefits.